SEC Contract Filing

Filing Date: 2016-08-24

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>whsi-20160823_8kex10z1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>

<P STYLE="font: 14pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>Amendment</B></P>

<P STYLE="font: 12pt/150% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Amendment dated
August 23, 2016 shall amend the Subscription Agreement and Warrant, each dated March 3, 2016 by and between Wearable Health Solutions
Inc. F/K/A Medical Alarm Concepts Holdings, Inc. (the &ldquo;Company&rdquo;) and Benza Pharma, LLC (&ldquo;Benza&rdquo;) (the &ldquo;Subscription
Agreement&rdquo;).</P>

<P STYLE="font: 12pt/150% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant
to the Subscription Agreement, Benza purchased a convertible promissory note in the principal amount of $660,000 (the &ldquo;Note&rdquo;)
and a warrant (the &ldquo;Warrant&rdquo;) to purchase 6,666,672 shares of Series C Convertible Preferred Stock (the &ldquo;Series
C Preferred Stock&rdquo;);</P>

<P STYLE="font: 12pt/150% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Series
C Preferred Stock provides that from February 26, 2016 until February 25, 2017, the Series C Preferred Stock shall entitle the
holder thereof to that number of votes, on a pro rata basis with all other holders of Series C Preferred Stock, equal to that number
of common shares which is not less than 51% of the vote required to approve any action submitted to shareholders. After February
25, 2017, thereafter each share of Series C Preferred Stock shall entitle the holder to 10 votes per share of Series C Preferred
Stock owned by it.</P>

<P STYLE="font: 12pt/150% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">WHEREAS, the parties
desire to amend the Warrant to provide certain restrictions on the exercise of such Warrant;</P>

<P STYLE="font: 12pt/150% Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in
consideration of the foregoing premises and of the mutual agreements contained herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree
as follows:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 12pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">The Warrant is hereby amended to provide that the Warrant may not
be exercised by Benza at any time which would result in Benza beneficially owning more than 9.99% of the Company&rsquo;s voting
capital stock.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 12pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">Benza will sign the representation that they are not an Affiliate
of the Company attached as Exhibit A hereto.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 12pt">3.</FONT></TD><TD><FONT STYLE="font-size: 12pt">All other terms of the Subscription Agreement and Warrant shall remain unchanged.</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 1 -->
 <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
 <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
 <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 4.5pt; text-align: justify; text-indent: 31.5pt">IN WITNESS
WHEREOF, the undersigned have caused this Amendment to be duly executed as of the date first above written.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in; text-indent: 0.5in">WEARABLE HEALTH SOLUTIONS,
INC.</P>

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 -12pt 0; text-indent: 0.5in">/s/ Ronnie Adams</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">____________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">By: Ronnie Adams</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Title: Chief Executive Officer</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">BENZA PHARMA, LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;